VisusNano is an innovative biotechnology start-up company dedicated to transforming cataract surgery with their groundbreaking product. They have developed a drug-eluting intraocular lens that has the potential to revolutionize the treatment of cataracts. Cataract surgery, which involves replacing the cloudy lens with an artificial implant, is the most common surgical procedure performed worldwide.

However, it often leads to complications such as cell proliferation, infections, and inflammation. VisusNano's solution is a biodegradable polymer-based drug elution system that can be attached to the intraocular lens. This system enables a slow and controlled release of antibiotic, anti-inflammatory, and anti-proliferative agents, eliminating the need for eye drops and postoperative laser treatment.

By improving patient outcomes and reducing the risks associated with cataract surgery, VisusNano aims to enhance the quality of life for both human and veterinary patients. With a mission to revolutionize cataract surgery, VisusNano is at the forefront of advancing treatment options and improving the overall well-being of individuals with cataracts. Discover the future of cataract surgery with VisusNano